🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is intended to evaluate if 12 or 24 weeks of treatment with GSK3...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-01-28
Trial ID
NCT04676724
Treatments Being Tested
Chronic hepatitis B virus (HBV) infection is a significant worldwide medica...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-07-27
Trial ID
NCT04449029
Treatments Being Tested
This study will assess the safety, efficacy and immune response following t...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-03-22
Trial ID
NCT05276297
Treatments Being Tested
This is an open-label, randomized study to investigate subcutaneous (SC) be...
Status
Completed
Location
GSK Investigational Site
Start Date
2023-10-04
Trial ID
NCT06058390
Treatments Being Tested
This is a Phase 1, open-label, parallel-group study to evaluate the pharmac...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-09-07
Trial ID
NCT04971928
Treatments Being Tested
Hepatitis B virus (HBV) infection, especially chronic, is a significant wor...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-10-06
Trial ID
NCT04544956
Treatments Being Tested